Daan Gene Co., Ltd. (SHE:002030)
China · Delayed Price · Currency is CNY 6.71
-0.37 (-5.23%)
Jun 1, 2026, 3:04 PM CST
Daan Gene Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 9,417 | 8,365 | 7,972 | 13,585 | 21,838 | 28,153 | |
Market Cap Growth | 24.49% | 4.93% | -41.32% | -37.79% | -22.43% | -6.43% |
Enterprise Value | 8,665 | 7,838 | 7,487 | 13,110 | 20,131 | 25,683 |
Last Close Price | 6.71 | 5.96 | 5.68 | 9.66 | 13.36 | 16.25 |
PE Ratio | - | - | - | 129.81 | 4.04 | 7.78 |
Forward PE | - | 121.50 | 121.50 | 121.50 | 121.50 | 121.50 |
PS Ratio | 12.76 | 11.04 | 9.35 | 11.50 | 1.81 | 3.67 |
PB Ratio | 1.30 | 1.14 | 0.98 | 1.48 | 1.88 | 3.68 |
P/TBV Ratio | 1.42 | 1.25 | 1.09 | 1.58 | 1.97 | 3.89 |
P/FCF Ratio | 98.62 | 103.92 | 63.31 | 65.52 | 8.23 | 10.64 |
P/OCF Ratio | 30.32 | 26.18 | 26.54 | 17.42 | 5.26 | 8.52 |
PEG Ratio | - | 5.06 | 5.06 | 5.06 | 5.06 | 5.06 |
EV/Sales Ratio | 11.74 | 10.35 | 8.78 | 11.10 | 1.67 | 3.35 |
EV/EBITDA Ratio | - | - | - | - | 3.17 | 6.27 |
EV/EBIT Ratio | - | - | - | - | 3.31 | 6.58 |
EV/FCF Ratio | 90.75 | 97.38 | 59.46 | 63.23 | 7.59 | 9.71 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 | 0.05 |
Debt / EBITDA Ratio | - | - | - | 334.14 | 0.04 | 0.10 |
Debt / FCF Ratio | 1.29 | 1.37 | 1.30 | 1.76 | 0.09 | 0.15 |
Net Debt / Equity Ratio | -0.13 | -0.19 | -0.20 | -0.22 | -0.29 | -0.28 |
Net Debt / EBITDA Ratio | 4.59 | 5.42 | 4.44 | 172.13 | -0.52 | -0.53 |
Net Debt / FCF Ratio | -10.25 | -17.12 | -12.94 | -9.81 | -1.26 | -0.81 |
Asset Turnover | 0.08 | 0.08 | 0.08 | 0.09 | 0.96 | 0.90 |
Inventory Turnover | 3.75 | 3.87 | 2.87 | 2.63 | 8.38 | 4.85 |
Quick Ratio | 1.97 | 2.32 | 2.43 | 2.68 | 2.65 | 1.97 |
Current Ratio | 2.98 | 2.82 | 2.92 | 3.09 | 2.95 | 2.37 |
Return on Equity (ROE) | -12.03% | -10.07% | -10.86% | 0.69% | 56.32% | 59.44% |
Return on Assets (ROA) | -3.41% | -3.74% | -4.32% | -1.73% | 30.31% | 28.63% |
Return on Invested Capital (ROIC) | -7.91% | -8.66% | -10.43% | -2.92% | 75.80% | 79.01% |
Return on Capital Employed (ROCE) | -6.60% | -7.20% | -8.60% | -3.80% | 51.60% | 49.90% |
Earnings Yield | -9.51% | -8.90% | -11.61% | 0.77% | 24.78% | 12.85% |
FCF Yield | 1.01% | 0.96% | 1.58% | 1.53% | 12.14% | 9.40% |
Dividend Yield | - | - | - | 0.15% | 13.10% | 6.83% |
Payout Ratio | - | - | - | 2358.72% | 29.00% | 13.72% |
Buyback Yield / Dilution | -2.97% | -0.19% | 6.25% | -6.53% | - | - |
Total Shareholder Return | -2.97% | -0.19% | 6.25% | -6.38% | 13.10% | 6.83% |